Should You Buy BioHarvest Sciences Inc. Common Stock Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, BioHarvest Sciences Inc. Common Stock (BHST) carries a solid Quality of Company rating of 6.2/10. Trading at $1.78, our multi-model framework evaluates whether the company's financial profile offers a favorable risk-reward setup.
The short answer: 1 of 1 CirclFi valuation models project upside for BioHarvest Sciences Inc. Common Stock (BHST) at $1.77 — the model consensus leans bullish, with a Quality Score of 6.2/10 and Value-Trap risk of 0/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for BioHarvest Sciences Inc. Common Stock (BHST) in 2026?
What Is the Bull Case vs the Bear Case for BioHarvest Sciences Inc. Common Stock (BHST)?
| Bull case — $1.79 target (+1.1%) | Bear case |
|---|---|
| Industry tailwind: private label penetration could provide meaningful support for BioHarvest Sciences Inc. Common Stock's revenue and margin trajectory in the Packaged Foods space. | No active model flags significant downside for BHST. The low Value Trap score paints a constructive picture. |
How Does BHST Compare to Its Packaged Foods Peers?
Valuation data pages: GIS · BRCC · BGS · HAIN · NCRA · UMEW · TRWD · FAMI · LFVN · PPC · JJSF
Which Other Stocks Score Like BHST on Quality?
Closest companies to BHST’s Quality of Company score of 6.2/10, across all industries.
- TFX — Teleflex Incorporated (QOC 6.2) · analysis
- WVVI — Willamette Valley Vineyards, Inc. (QOC 6.2) · analysis
- TXMD — TherapeuticsMD, Inc. (QOC 6.2) · analysis
- FUFU — BitFuFu Inc. (QOC 6.2) · analysis
- CDXS — Codexis, Inc. (QOC 6.2) · analysis
- HIVE — HIVE Digital Technologies Ltd. (QOC 6.2) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
Which Packaged Foods Screens Does BHST Appear In?
So Is BioHarvest Sciences Inc. Common Stock (BHST) Worth Buying in 2026?
Our models don't have a clear verdict on BioHarvest Sciences Inc. Common Stock. At $1.78 vs. $1.79 median fair value, the median upside of +1.1% masks significant model disagreement (+0.0% spread). With quality at 6.2/10, this is a stock where the margin of error is wide and additional fundamental research is strongly recommended.
These are quantitative model outputs, not investment recommendations. BioHarvest Sciences Inc. Common Stock's future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About BHST Stock?
Should I buy BHST stock right now?
Based on CirclFi's multi-model analysis, 1 of 1 models see upside for BHST at $1.77. The majority of models suggest the stock trades below fair value, but investors should weigh this against the Quality Score of 6.2/10 and individual risk tolerance. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in BioHarvest Sciences Inc. Common Stock?
Key risks include: limited model coverage (1/13 active), reducing analytical confidence; general market and sector-specific risks affecting Packaged Foods companies. Always diversify and consult a financial advisor.
How does BHST compare to its competitors?
Among Packaged Foods peers, BHST holds a Quality Score of 6.2/10. Comparable companies include GIS (QOC 6.2), BRCC (QOC 6.0), BGS (QOC 6.3). The relative ranking helps investors identify whether BHST offers better fundamental quality than alternatives in the same sector.
Is BHST a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. BHST's Quality Score of 6.2/10 suggests moderate fundamentals — not a clear long-term hold without further research into growth catalysts. Check our full data page for all 13 model estimates.
What price should I buy BHST at?
CirclFi does not provide target buy prices or price alerts. However, our 1 active models produce fair value estimates ranging from $1.79 to $1.79. At $1.77, the stock trades below even the most conservative estimate, which may represent a margin of safety — or reflect risks the models don't capture. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for BHST.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad